KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Ginkgo Bioworks Holdings (DNA) Receivables - Net (2020 - 2025)

Ginkgo Bioworks Holdings (DNA) has disclosed Receivables - Net for 4 consecutive years, with $1.2 million as the latest value for Q3 2023.

  • For the quarter ending Q3 2023, Receivables - Net fell 98.9% year-over-year to $1.2 million, compared with a TTM value of $1.2 million through Sep 2023, down 98.9%, and an annual FY2022 reading of $80.9 million, down 38.49% over the prior year.
  • Receivables - Net was $1.2 million for Q3 2023 at Ginkgo Bioworks Holdings, up from $899000.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $171.6 million in Q2 2022 and bottomed at $899000.0 in Q2 2023.
  • Average Receivables - Net over 4 years is $81.2 million, with a median of $82.1 million recorded in 2022.
  • The sharpest move saw Receivables - Net skyrocketed 687.97% in 2021, then plummeted 99.48% in 2023.
  • Year by year, Receivables - Net stood at $16.7 million in 2020, then surged by 687.97% to $131.5 million in 2021, then crashed by 38.49% to $80.9 million in 2022, then tumbled by 98.46% to $1.2 million in 2023.
  • Business Quant data shows Receivables - Net for DNA at $1.2 million in Q3 2023, $899000.0 in Q2 2023, and $83.3 million in Q1 2023.